{"id":"W2067573216","doi":"10.1016/j.eururo.2012.09.007","title":"A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Prostate cancer; Osteoporosis; Placebo; Androgen deprivation therapy; Cancer; Oncology; Internal medicine; Randomized controlled trial; Urology; Prostate; Gynecology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002286663,0.003145755,0.0079028,0.0008767149,0.0009966618,0.001409703,0.001798429,0.003394273,0.008541996],"category_scores_gemma":[0.00241087,0.00151773,0.002787572,0.0007346474,0.00234086,0.001610321,0.0006724926,0.004999219,0.002020153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007894686,"about_ca_system_score_gemma":0.001796998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001914716,"about_ca_topic_score_gemma":0.003507343,"domain_scores_codex":[0.9991199,0.0003658673,0.00006104189,0.000192313,0.00009021286,0.0001706148],"domain_scores_gemma":[0.9985306,0.0003485027,0.0002214443,0.0001929292,0.0001188578,0.0005875712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.98202,0.01002752,0.0001737791,0.0003190836,0.0005529003,0.00001845912,0.00003538965,0.0001562899,0.001832031,0.00005062226,0.0003651168,0.004448784],"study_design_scores_gemma":[0.9767248,0.02221373,0.0004477786,0.000006326553,0.0001531324,0.000007375408,0.000007487204,0.0001052494,0.0001177365,0.00005012437,0.0001577189,0.00000848739],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766516,0.003982791,0.00172904,0.001050289,0.001158517,0.009874819,0.002498899,0.0004903689,0.00256368],"genre_scores_gemma":[0.9604263,0.00467826,0.004510911,0.002884982,0.001309656,0.01552517,0.002840287,0.0001367087,0.007687737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008541996,"threshold_uncertainty_score":0.02857584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08995542459046717,"score_gpt":0.3921568895774073,"score_spread":0.3022014649869401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}